Detalles de la búsqueda
1.
Asian participants' experience in phase 3/3b studies of long-acting cabotegravir and rilpivirine: Efficacy, safety, pharmacokinetic, and virological outcomes through week 96.
HIV Med
; 25(3): 381-390, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38147871
2.
Efficacy, safety, and pharmacokinetics by BMI category in Phase 3/3b cabotegravir + rilpivirine long-acting trials.
J Infect Dis
; 2023 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38134313
3.
Compassionate use of long-acting cabotegravir plus rilpivirine for people living with HIV-1 in need of parenteral antiretroviral therapy.
HIV Med
; 24(2): 202-211, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35945163
4.
Pregnancy outcomes and pharmacokinetics in pregnant women living with HIV exposed to long-acting cabotegravir and rilpivirine in clinical trials.
HIV Med
; 24(5): 568-579, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36411596
5.
Clinical burden of invasive Escherichia coli disease among older adult patients treated in hospitals in the United States.
BMC Infect Dis
; 23(1): 550, 2023 Aug 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37608247
6.
Week 96 resistance analyses of the once-daily, single-tablet regimen (STR) darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in adults living with HIV-1 from the phase 3 randomized AMBER and EMERALD trials.
J Med Virol
; 93(6): 3985-3990, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33300183
7.
Effects of once-daily darunavir/ritonavir versus atazanavir/ritonavir on insulin sensitivity in HIV-infected persons over 48 weeks: results of an exploratory substudy of METABOLIK, a phase 4, randomized trial.
HIV Clin Trials
; 17(2): 72-7, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26917112
8.
Comparison of the metabolic effects of ritonavir-boosted darunavir or atazanavir versus raltegravir, and the impact of ritonavir plasma exposure: ACTG 5257.
Clin Infect Dis
; 60(12): 1842-51, 2015 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25767256
9.
Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial.
Ann Intern Med
; 161(7): 461-71, 2014 Oct 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-25285539
10.
HIV testing practices among black primary care physicians in the United States.
BMC Public Health
; 13: 96, 2013 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-23375193
11.
Economic burden of invasive Escherichia coli disease among older adult patients treated in hospitals in the United States.
J Manag Care Spec Pharm
; 29(8): 873-883, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37523312
12.
Low Incidence and Brief Duration of Gastrointestinal Adverse Events with Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Over 96 Weeks: Post hoc Analyses of AMBER and EMERALD.
J Int Assoc Provid AIDS Care
; 21: 23259582221088202, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35466761
13.
Week 96 subgroup analyses of the phase 3, randomized AMBER and EMERALD trials evaluating the efficacy and safety of the once daily darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) single-tablet regimen in antiretroviral treatment (ART)-naïve and -experienced, virologically-suppressed adults living with HIV-1.
HIV Res Clin Pract
; 21(6): 151-167, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33528318
14.
Week 48 Resistance Analyses of the Once-Daily, Single-Tablet Regimen Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase III Randomized AMBER and EMERALD Trials.
AIDS Res Hum Retroviruses
; 36(1): 48-57, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31516033
15.
Bioequivalence of the Once-Daily Single-Tablet Regimen of Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide Compared to Combined Intake of the Separate Agents and the Effect of Food on Bioavailability.
Clin Pharmacol Drug Dev
; 8(4): 480-491, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30412360
16.
Pharmacokinetics of Total and Unbound Etravirine in HIV-1-Infected Pregnant Women.
J Acquir Immune Defic Syndr
; 73(3): 268-274, 2016 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27159225
17.
Trends in darunavir resistance-associated mutations and phenotypic resistance in commercially tested United States clinical samples between 2006 and 2012.
AIDS Res Hum Retroviruses
; 31(6): 628-35, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25684627
Resultados
1 -
17
de 17
1
Próxima >
>>